Francis Patrick Ostronic is Director of Cyclo Therapeutics, Inc.. Currently has a direct ownership of 419,100 shares of CYTH, which is worth approximately $301,752. The most recent transaction as insider was on Nov 19, 2021, when has been sold 10,652 shares (Common Stock) at a price of $5.24 per share, resulting in proceeds of $55,816. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 419K
0% 3M change
20.16% 12M change
Total Value Held $301,752

Francis Patrick Ostronic Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2021
BUY
Open market or private purchase
$55,816 $5.24 p/Share
10,652 Added 10.77%
88,211 Common Stock
Oct 29 2021
BUY
Open market or private purchase
$5,900 $5.9 p/Share
1,000 Added 1.27%
77,559 Common Stock
Apr 16 2021
BUY
Open market or private purchase
$65,300 $6.53 p/Share
10,000 Added 11.55%
76,559 Common Stock
Apr 12 2021
BUY
Open market or private purchase
$35,000 $7.0 p/Share
5,000 Added 6.99%
66,559 Common Stock
Mar 29 2021
BUY
Open market or private purchase
$22,500 $7.5 p/Share
3,000 Added 4.65%
61,559 Common Stock
Dec 17 2020
BUY
Open market or private purchase
$139,200 $4.64 p/Share
30,000 Added 33.88%
58,559 Common Stock
FPO

Francis Patrick Ostronic

Director
Gainesville, FL

Track Institutional and Insider Activities on CYTH

Follow Cyclo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTH shares.

Notify only if

Insider Trading

Get notified when an Cyclo Therapeutics, Inc. insider buys or sells CYTH shares.

Notify only if

News

Receive news related to Cyclo Therapeutics, Inc.

Track Activities on CYTH